Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Department of Pathology

CHU/Universite de Poitiers

Poitiers

France; Centre d'Etude et de Recherche sur les Pathologies Prostatiques

France

Name/email consistency: high

Department of Pathology, CHU/Universite de Poitiers, Poitiers, France; Centre d'Etude et de Recherche sur les Pathologies Prostatiques, France. 2012
Service d'Anatomie Pathologique, CHU, Université de Poitiers, Poitiers, France. 2009 - 2011
CeRePP, EA 3104, Universite Paris VII, and Department of Urology, France. 2005 - 2007

BCAR1 expression improves prediction of biochemical reccurence after radical prostatectomy. Fromont, G., Rozet, F., Cathelineau, X., Ouzzane, A., Doucet, L., Fournier, G., Cussenot, O. Prostate (2012) [Pubmed]
Biological significance of perineural invasion (PNI) in Prostate cancer. Fromont, G., Godet, J., Pires, C., Yacoub, M., Dore, B., Irani, J. Prostate (2011) [Pubmed]
Revisiting the immunophenotype of nephrogenic adenoma. Fromont, G., Barcat, L., Gaudin, J., Irani, J. Am. J. Surg. Pathol. (2009) [Pubmed]
BCAR1 expression in prostate cancer: association with 16q23 LOH status, tumor progression and EGFR/KAI1 staining. Fromont, G., Vallancien, G., Validire, P., Levillain, P., Cussenot, O. Prostate (2007) [Pubmed]
Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer. Fromont, G., Valeri, A., Cher, M., Pontes, J.E., Vallancien, G., Validire, P., Latil, A., Cussenot, O. Prostate (2005) [Pubmed]